<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="163022">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01774396</url>
  </required_header>
  <id_info>
    <org_study_id>08-2012</org_study_id>
    <nct_id>NCT01774396</nct_id>
  </id_info>
  <brief_title>Use Of Three Commercial Preparations Of Injectable Hyaluronic Acid In Hands Rejuvenation</brief_title>
  <official_title>Clinical Trial On The Use Of Three Commercial Preparations Of Injectable Hyaluronic Acid (Emervel® Volume Lidocaine, Emervel® Deep Lidocaine And Emervel® Touch) In Hands Rejuvenation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brazilan Center for Studies in Dermatology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brazilan Center for Studies in Dermatology</source>
  <oversight_info>
    <authority>Brazil: National Committee of Ethics in Research</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assessment of efficacy of hyaluronic acid - Emervel® Volume Lidocaine combined or not with
      Emervel® Touch and Emervel® Deep Lidocaine combined or not with Emervel® Touch in female
      patients with loss of fatty tissue in hands.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Efficacy of hyaluronic acid - Emervel® Volume Lidocaine combined or not with Emervel® Touchand Emervel® Deep Lidocaine combined or not with Emervel® Touch in subjects with with loss of fatty tissue</measure>
    <time_frame>at baseline and up to 180 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assessment of efficacy of hyaluronic acid - Emervel® Volume Lidocaine combined or not with Emervel® Touch (Galderma) and Emervel® Deep Lidocaine combined or not with Emervel® Touch (Galderma) in female patients with loss of fatty tissue as a sign of aging on hands by Global Aesthetic Improvement scale1 and Hand Grading Scale2.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Hands Rejuvenation</condition>
  <arm_group>
    <arm_group_label>group 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Emervel® Volume Lidocaine alone in the dorsa of one hand and Emervel® Deep Lidocaine alone in the dorsa of the contralateral hand.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Emervel® Volume Lidocaine plus Emervel® Touch in the dorsa of one hand and Emervel® Deep Lidocaine plus Emervel® Touch in the dorsa of the contralateral hand</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Emervel® Touch</intervention_name>
    <description>Emervel® Touch will be injected only in the intervention group.</description>
    <arm_group_label>group 1</arm_group_label>
    <other_name>Emervel® Touch</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Emervel® Volume Lidocaine and Emervel® Deep Lidocaine</intervention_name>
    <description>Emervel® Volume Lidocaine and Emervel® Deep Lidocaine will be injected in the group #2.</description>
    <arm_group_label>group 2</arm_group_label>
    <arm_group_label>group 1</arm_group_label>
    <other_name>Emervel® Volume Lidocaine and Emervel® Deep Lidocaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects agreeing to take part of all procedures of the study (including pre-test,
             filler injection, photographs, etc.), after being fully informed on the objectives
             and nature of the investigations;

          -  Written Informed Consent;

          -  Treatment-naive patients for fillers in hands;

          -  Subjects of both genders over 18 years;

          -  Fitzpatrick skin phototypes I to VI;

          -  Subjects presenting a similar loss of fatty tissue on both hands, at least of 2
             according the Validated Hand Grading Scale2;

          -  Medical history and physical examination which, based on the investigator's opinion,
             do not prevent the patient from taking part in the study and use the product under
             investigation;

          -  Female subjects of childbearing age should present a negative urine pregnancy test
             and should be using an effective contraceptive method;

          -  Availability of the subject throughout the duration of the study (208 days);

          -  Subjects with sufficient schooling and awareness to enable them to cooperate to the
             degree required by this protocol.

        Exclusion Criteria:

          -  Pregnant women or women intending to become pregnant in the next 18 months;

          -  Subjects with known hypersensitivity to any hyaluronic acid products;

          -  Subjects with history of adverse effects, such as sensitivity to the components of
             the formula, or any other adverse effect, which in the investigator's opinion should
             prevent the patient from participating in the study;

          -  Subjects participating in other clinical trials;

          -  Any prior surgery or side effects at the hands area, or any prior cosmetic
             procedures, including permanent fillers, that may interfere with the results;

          -  Subjects with active inflammation or infection in the area to be treated;

          -  Subjects with a history of medical treatment non-adherence or showing unwillingness
             to adhere to the study protocol;

          -  Subjects presenting diseases such as coagulation disorders or under the use of
             anticoagulants, or any condition that, in the opinion of the investigator, can
             compromise the evaluation of the study.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Brazilian center of Dermatology Studies</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <zip>90570-040</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 13, 2013</lastchanged_date>
  <firstreceived_date>December 28, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brazilan Center for Studies in Dermatology</investigator_affiliation>
    <investigator_full_name>Doris Hexsel</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Hands Rejuvenation, fillers</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hyaluronic Acid</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
